Research Article |
Corresponding author: Yevhen Karpun ( ekarpun@yahoo.com ) Academic editor: Plamen Peikov
© 2023 Yevhen Karpun, Sergiy Fedotov, Anastasiia Khilkovets, Yuriy Karpenko, Volodymyr Parchenko, Yana Klochkova, Yuliia Bila, Iryna Lukina, Natalia Nahorna, Volodymyr Nahornyi.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Karpun Y, Fedotov S, Khilkovets A, Karpenko Y, Parchenko V, Klochkova Y, Bila Y, Lukina I, Nahorna N, Nahornyi V (2023) An in silico investigation of 1,2,4-triazole derivatives as potential antioxidant agents using molecular docking, MD simulations, MM-PBSA free energy calculations and ADME predictions. Pharmacia 70(1): 139-153. https://doi.org/10.3897/pharmacia.70.e90783
|
In this study, we’ve performed computable studies of previously synthesized 1,2,4-triazole derivatives by virtual screening due to antioxidant activity. Six enzymes responsible for regulating oxidative stress were selected as key targets. One hundred and twelve compounds were subjected to semi-flexible molecular docking, which resulted in the selection of 23 substances based on binding energy for further ADME analysis. In addition, molecular dynamics studies of complexes with the best docking scores, reference complexes and apo-proteins were described in detail here. The results of 100 ns modeling (RMSD, RMSF, SASA, Rg, PCA) indicate great stability during the formation of complexes with our two potential compounds, as well as favorable binding energy, which was determined theoretically by means of the MM/PBSA method, thereby increase the likelihood of their acting as promising inhibitors of selected enzymes.
1,2,4-Triazole, Molecular docking, vMolecular dynamic simulations, MM-PBSA, Antioxidant activity
Oxidative stress is an unavoidable metabolic process for all living organisms, in which there is an imbalance between the Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) and the mechanisms of antioxidant protection. Reactive species of N and O are formed during chain reactions during the oxidation of fats and oils are responsible for damage to biomolecules, DNA, proteins, lipids and are the cause of many chronic diseases (
Tyrosinase is an enzyme that regulates the rate of melanin production, and its abnormal accumulation causes various skin diseases. Therefore, tyrosinase inhibitors are necessary to ensure normal melanin content (
1,2,4-triazoles and their derivatives represent a huge class of heterocyclic compounds that have a wide range of pharmacological activity. They can easily bind to biotargets, since they demonstrate good stability in various media, while increasing the ability to form hydrogen bonds, Dipole-Dipole and π-stacking interactions. The presence of specific functional capabilities in combination with practical non-toxicity (
Selected enzymes capable of regulating oxidative processes have already been the subject of research. For example, works (
In this work, our goal was to perform virtual screening of 112 previously synthesized compounds (
The studied derivatives of S-substituted 4-R1-5-(((3-(pyridine-4-yl)-1H-1,2,4-triazole-5-yl)thio)methyl)-4H-1,2,4-triazole-3-thiols, 5-(thiophene-3-ylmethyl)-4-R1-1,2,4-triazole-3-thiol, 3-(ethylthio)-9-methylpyrazolo[1,5-d][1,2,4]triazolo[3,4-F][1,2,4]triazine-6-alkylthio, 4-amino-5-(3-methyl-1H-pyrazol-5-yl)-4h-1,2,4-triazole-3-alkylthio, 9-methylpyrazolo[1,5-d][1,2,4]triazolo[3,4-F][1,2,4]triazine-3-alkylthio, which are presented in Scheme 1, they have been synthesized by us earlier, and their physico-chemical parameters and structure’s evidence are presented in the works (
In this study, 6 enzymes were selected from the RCSB protein database that are somehow responsible for controlling oxidative stress in the body: peroxiredoxin (peroxidase) (PDB: 3MNG), – is associated with antioxidant protection; NO-synthase (PDB: :6NGJ); NADPH – oxidase (PDB: 2CDU); tyrosinase: limits the rate of melanogenesis (PDB: 3NM8); NMDA receptor (PDB: 4KFQ); hemoxygenase, is an important stress protein which takes part in cell defense, antioxidant, and anti-inflammatory activity (PDB: 1N3). The receptors were prepared using OpenBabel-2.4.1 and Molegro Molecular Viewer (
The ADME properties of the selected compounds were predicted by the freely available SwissADME software (
To determine the mechanism of binding and interaction of selected compounds and targets, molecular docking studies were performed using Smina (
Receptors in complexes with calculated and experimental ligand conformation: peroxiredoxin-5 bond with (4S,5S)-1,2-dityan-4,5-diol (A), hemoxygenase 1 with protoporphyrin IX (B), ionotropic glutamate receptor (NMDA 1) with 1-sulfonyl[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (C), NO-synthase with 6-(3-fluoro-5-(3-(methylamino)prop-1-in-1-yl)phenethyl)-4-methylpyridine-2-amine (D).
Similarity in overlapping crystallographic poses (orientation + conformation, blue) and calculated ones (yellow) was obtained by molecular docking and graphically reflects a low RMSD value, which characterizes good results according to the literature data. Active sites are the ligand coordinates in the original target protein networks, and these active target receptor binding sites were analyzed and determined by means of Chimera 1.16. PyMOL v.2.5 (Schrodinger, New York) and Discovery studio Visualizer (
Receptor | Reference ligand | Coordinates of the center Grid Box | Size Grid Box |
---|---|---|---|
Peroxidase (PDB: 3MNG) | (4S,5S)-1,2- dityan-4,5-diol | 7.96 x | 16 x |
42.45 y | 16 y | ||
32.35 z | 16 z | ||
NO- synthase (PDB: 6NGJ) | 6-(3-fluoro-5-(3-(methylamino)prop-1-in-1-yl)phenethyl)-4-methylpyridine-2-amine | 10.92 x | 22 x |
2.92 y | 22 y | ||
27.24 z | 26 z | ||
NADPH oxidase (PDB: 2CDU) | adenosine-5’-diphosphate | 19.12 x | 22 x |
-5.23 y | 22 y | ||
-0.07 z | 22 z | ||
Tyrosinase (PDB: 3NM8) | 5-hydroxy-2-(hydroxymethyl)-4h-pyran-4-one | 1.68 x | 30 x |
9.88 y | 14 y | ||
54.96 z | 32 z | ||
NMDA-receptor GluN1 (PDB: 4KFQ) | 1-sulfonyl[1,2,4]triazolo [4,3-a]quinoxalin-4 (5H)-one | 27.51 x | 18 x |
34.68 y | 18 y | ||
46.90 z | 18 z | ||
Hemoxygenase (PDB: 1N3U) | protoporphyrin IX | 25.92 x | 22 x |
17.39 y | 18 y | ||
-36.81 z | 20 z |
The ideal position of each molecule was selected according to the energy index and the best fit to the active center with the lowest RMSD index. The lower ∆G, the more significant the interaction between the receptor and the ligands.
In the given study, we’ve conducted two molecular dynamic modeling experiments to support our design concept. Two complexes were taken as a basis, where the ligands had the lowest energy conformation, which also exceeded the indicators of crystallographic comparison preparations. The first experiment was for NO-synthase (PDB: 6NGJ) in complex with 2.15, and the second for the NMDA-receptor (PDB: 4KFQ) with compound 3.14. MD simulations were performed in a GROMACS 2202.2 (
The molecular Mechanic / Poisson-Boltzmann Surface Area (MM-PBSA) (
ΔGbinding = ΔGcomplex – (ΔGprotein + ΔGligand) (1)
In addition, the individual free energies for a complex, protein, or ligand can be calculated using the equation (2):
ΔG = (EMM) + Gsolvation (2)
Where (EMM) is the average potential energy of molecular mechanics without taking into account pressure. The average free solvation energy consists of two parts: polar and nonpolar (3):
ΔGsolvation = ΔGpolar + ΔGnonpolar (3)
That is, the binding energy consists of three energy terms of the system’s individual components: potential energy in vacuum, polar solvation energy, and nonpolar solvation energy. A full description of the MM/PBSA protocol was obtained from the Web page (http://rashmikumari.github.io/g_mmpbsa/).
Molecular docking was used to identify the mechanism of interaction between ligands and receptors as the primary method of virtual screening. Docking studies were conducted for 112 compounds due to six enzymes responsible for regulating of the oxin process. Nine conformational positions were created for each compound and one with the best affinity value was selected, which is presented in the Table
Compound | Docking score for selected proteins (kcal/mol) | Compound | Docking score for selected proteins (kcal/mol) | Compound | Docking score for selected proteins (kcal/mol) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6NGJ | 4KFQ | 1N3U | 3NM8 | 3NMG | 2CDU | 6NGJ | 4KFQ | 1N3U | 3NM8 | 3NMG | 2CDU | 6NGJ | 4KFQ | 1N3U | 3NM8 | 3NMG | 2CDU | |||
1.1 | -7.9 | -7.8 | -7.2 | -6.7 | -4.7 | -7.0 | 1.20 | -8.3 | -8.3 | -6.9 | -6.5 | -5.7 | -7.9 | 3.18 | -8.0 | -8.2 | -7.1 | -6.2 | -5.1 | -7.2 |
2.1 | -7.7 | -7.8 | -7.1 | -6.5 | -4.8 | -7.1 | 2.20 | -8.0 | -8.4 | -7.3 | -6.3 | -4.8 | -7.4 | 3.19 | -9.9 | -10.3 | -9.1 | -7.2 | -5.9 | -8.4 |
1.2 | -7.7 | -7.8 | -7.0 | -6.7 | -5.0 | -6.9 | 1.21 | -8.2 | -8.3 | -7.4 | -6.1 | -5.5 | -7.6 | 4.19 | -8.6 | -7.7 | -6.6 | -6.1 | -4.5 | -7.3 |
2.2 | -7.7 | -8.0 | -7.1 | -6.0 | -5.1 | -7.0 | 2.21 | -8.2 | -7.8 | -7.7 | -6.0 | -4.9 | -7.5 | 5.1 | -7.8 | -7.3 | -6.7 | -5.8 | -4.5 | -6.8 |
1.3 | -7.6 | -7.9 | -7.0 | -6.3 | -4.5 | -7.1 | 1.22 | -7.7 | -8.2 | -7.4 | -6.6 | -5.1 | -7.8 | 6.1 | -8.1 | -7.4 | -6.6 | -5.5 | -4.2 | -6.6 |
2.3 | -7.7 | -8.1 | -7.4 | -6.7 | -4.7 | -7.1 | 2.22 | -7.9 | -8.1 | -7.4 | -6.4 | -4.9 | -7.5 | 7.1 | -8.1 | -7.7 | -6.8 | -5.4 | -4.2 | -6.5 |
1.4 | -7.8 | -8.2 | -7.6 | -6.3 | -4.7 | -7.4 | 1.23 | -7.9 | -8.5 | -7.5 | -6.7 | -4.8 | -7.6 | 5.2 | -8.1 | -7.8 | -6.4 | -5.5 | -4.6 | -6.9 |
2.4 | -8.1 | -7.8 | -6.9 | -6.1 | -4.6 | -7.5 | 2.23 | -8.2 | -7.9 | -7.6 | -6.5 | -4.8 | -7.7 | 6.2 | -8.1 | -7.7 | -6.5 | -5.4 | -4.7 | -6.5 |
1.5 | -7.9 | -8.0 | -7.2 | -5.3 | -4.9 | -7.5 | 1.24 | -7.9 | -8.3 | -7.1 | -6.3 | -4.7 | -7.7 | 7.2 | -8.1 | -7.7 | -6.6 | -5.4 | -4.8 | -6.4 |
2.5 | -7.8 | -7.8 | -7.1 | -5.7 | -4.7 | -7.7 | 2.24 | -7.9 | -8.1 | -7.3 | -6.3 | -4.7 | -7.6 | 5.3 | -8.0 | -7.6 | -6.7 | -5.4 | -4.9 | -6.4 |
1.6 | -7.5 | -7.4 | -6.8 | -5.5 | -5.1 | -7.5 | 1.25 | -8.4 | -8.9 | -8.1 | -6.7 | -5.5 | -7.9 | 6.3 | -7.9 | -7.4 | -6.4 | -5.4 | -4.8 | -6.4 |
2.6 | -7.6 | -7.7 | -6.8 | -5.6 | -4.6 | -7.5 | 2.25 | -8.6 | -8.8 | -7.8 | -7.0 | -5.5 | -8.2 | 7.3 | -7.7 | -7.3 | -6.2 | -5.5 | -4.9 | -6.4 |
1.7 | -7.6 | -7.8 | -7.0 | -6.4 | -4.9 | -7.0 | 1.26 | -9.1 | -9.1 | -8.0 | -6.9 | -5.4 | -8.9 | 5.4 | -7.7 | -7.3 | -6.2 | -5.4 | -4.8 | -6.3 |
2.7 | -7.9 | -7.9 | -7.0 | -6.2 | -4.7 | -7.0 | 2.26 | -9.2 | -8.9 | -8.2 | -6.9 | -5.4 | -8.6 | 6.4 | -7.7 | -7.3 | -6.3 | -5.2 | -5.0 | -6.4 |
1.8 | -7.7 | -7.9 | -6.8 | -6.3 | -4.3 | -7.1 | 3.1 | -7.9 | -7.6 | -6.6 | -5.4 | -5.0 | -6.9 | 7.4 | -8.0 | -7.5 | -5.9 | -5.9 | -5.3 | -6.8 |
2.8 | -8.2 | -8.3 | -7.4 | -5.9 | -4.3 | -7.2 | 4.1 | -5.8 | -5.9 | -5.0 | -4.2 | -4.4 | -5.4 | 5.5 | -7.9 | -7.5 | -6.4 | -5.3 | -5.3 | -7.1 |
1.9 | -8.0 | -8.2 | -7.3 | -5.8 | -4.4 | -7.3 | 3.2 | -7.6 | -7.7 | -6.7 | -5.5 | -4.7 | -6.5 | 6.5 | -7.8 | -7.3 | -6.4 | -5.6 | -5.1 | -6.8 |
2.9 | -7.8 | -8.0 | -7.4 | -6.3 | -4.9 | -7.4 | 4.2 | -6.0 | -5.9 | -5.0 | -4.6 | -4.3 | -5.5 | 7.5 | -7.9 | -7.4 | -6.1 | -5.5 | -5.3 | -6.8 |
1.10 | -7.8 | -7.7 | -6.8 | -5.2 | -4.5 | -7.5 | 3.3 | -9.0 | -8.2 | -6.8 | -6.1 | -4.8 | -6.7 | 5.6 | -7.9 | -7.8 | -5.9 | -6.3 | -5.2 | -6.8 |
2.10 | -8.3 | -7.8 | -6.6 | -6.2 | -4.5 | -7.5 | 4.3 | -6.5 | -6.9 | -5.9 | -5.1 | -4.4 | -6.0 | 6.6 | -8.0 | -7.7 | -6.6 | -5.5 | -5.2 | -6.7 |
1.11 | -7.8 | -7.4 | -7.1 | -6.1 | -4.8 | -7.3 | 4.4 | -7.3 | -6.5 | -5.7 | -5.0 | -4.5 | -6.5 | 7.6 | -7.9 | -7.5 | -6.5 | -5.7 | -5.1 | -6.6 |
2.11 | -7.9 | -7.8 | -6.6 | -5.9 | -4.9 | -7.6 | 3.5 | -7.5 | -8.2 | -7.1 | -5.8 | -4.8 | -6.9 | 5.7 | -7.8 | -7.6 | -6.3 | -6.4 | -5.0 | -6.6 |
1.12 | -8.8 | -8.8 | -7.8 | -7.1 | -5.2 | -9.2 | 3.6 | -7.6 | -8.1 | -7.0 | -5.2 | -4.8 | -6.7 | 6.7 | -7.4 | -7.3 | -6.0 | -6.3 | -4.9 | -6.2 |
2.12 | -8.9 | -8.9 | -7.7 | -6.5 | -5.5 | -9.1 | 4.6 | -6.8 | -6.6 | -5.6 | -4.2 | -4.4 | -5.4 | 7.7 | -7.3 | -6.9 | -5.8 | -5.9 | -4.7 | -5.9 |
1.13 | -8.2 | -8.3 | -7.4 | -6.3 | -5.5 | -7.3 | 4.7 | -8.7 | -7.9 | -6.5 | -5.7 | -4.9 | -7.5 | 5.8 | -7.3 | -6.9 | -5.8 | -5.4 | -4.7 | -5.9 |
2.13 | -7.5 | -8.2 | -7.4 | -6.0 | -5.6 | -7.2 | 3.8 | -8.0 | -8.2 | -7.1 | -6.2 | -5.1 | -7.2 | 6.8 | -8.4 | -7.1 | -6.4 | -6.3 | -5.4 | -6.5 |
1.14 | -9.5 | -9.1 | -7.9 | -7.2 | -5.0 | -9.2 | 4.8 | -7.1 | -6.9 | -6.0 | -5.7 | -4.8 | -6.7 | 7.8 | -8.3 | -7.1 | -5.9 | -6.6 | -5.4 | -6.7 |
2.14 | -9.7 | -9.1 | -8.7 | -7.1 | -5.3 | -9.3 | 4.9 | -6.8 | -6.9 | -6.0 | -5.6 | -4.3 | -6.4 | 5.9 | -8.2 | -7.2 | -6.5 | -6.7 | -5.3 | -6.8 |
1.15 | -9.8 | -9.5 | -7.9 | -7.0 | -5.1 | -9.1 | 4.10 | -8.7 | -8.1 | -6.6 | -6.0 | -5.2 | -7.4 | 6.9 | -7.7 | -7.2 | -6.5 | -6.6 | -5.2 | -6.6 |
2.15 | -10.4 | -9.5 | -8.4 | -6.9 | -5.4 | -8.9 | 3.11 | -9.0 | -8.9 | -6.8 | -5.8 | -5.1 | -7.4 | 7.9 | -7.5 | -7.2 | -6.6 | -6.8 | -5.2 | -6.6 |
1.16 | -9.7 | -8.8 | -7.4 | -7.2 | -5.6 | -9.1 | 3.12 | -8.7 | -8.6 | -7.1 | -6.6 | -5.1 | -7.5 | 5.10 | -7.5 | -7.4 | -6.5 | -7.0 | -5.1 | -6.6 |
2.16 | -9.5 | -9.5 | -7.7 | -7.2 | -5.0 | -8.0 | 4.13 | -7.5 | -7.5 | -6.5 | -7.0 | -5.3 | -7.1 | 6.10 | -7.4 | -7.2 | -6.4 | -6.9 | -5.1 | -6.4 |
1.17 | -7.9 | -7.8 | -7.2 | -6.7 | -4.9 | -7.2 | 3.14 | -9.5 | -10.1 | -8.5 | -7.2 | -5.8 | -8.3 | 7.10 | -6.7 | -7.1 | -6.1 | -7.0 | -5.0 | -6.1 |
2.17 | -9.5 | -9.7 | -8.2 | -7.2 | -5.1 | -8.0 | 4.14 | -8.8 | -8.4 | -7.4 | -6.5 | -5.3 | -7.5 | 5.11 | -6.7 | -6.7 | -5.8 | -7.0 | -4.8 | -5.9 |
1.18 | -8.5 | -8.4 | -7.0 | -6.5 | -5.8 | -8.1 | 4.15 | -8.7 | -8.3 | -7.1 | -6.3 | -5.2 | -7.5 | 6.11 | -6.7 | -6.4 | -5.6 | -6.9 | -4.8 | -5.8 |
2.18 | -8.6 | -8.5 | -7.5 | -6.3 | -5.7 | -8.2 | 3.16 | -10.1 | -9.6 | -8.1 | -7.4 | -5.4 | -8.8 | 7.11 | -6.8 | -6.4 | -5.5 | -6.8 | -5.0 | -5.7 |
1.19 | -7.7 | -8.0 | -7.4 | -6.7 | -4.9 | -7.7 | 3.17 | -8.2 | -8.3 | -7.1 | -6.0 | -4.9 | -7.1 | r. l.* | -9.7 | -8.4 | -10.4 | -7.9 | -3.7 | -10.3 |
2.19 | -8.5 | -8.3 | -7.4 | -6.2 | -4.7 | -7.6 | 4.17 | -6.8 | -6.7 | -5.7 | -5.6 | -4.7 | -6.5 |
Twenty-three found hits that exceeded the docking value of the comparison ligands were subjected to ADME analysis using the SwissADME server (Table
Molecule | MW | H-bond acceptors | H-bond donors | TPSA | Consensus Log P | Ali Log S | Lipinski #violations | BBB permeant | Pgp substrate | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 inhibitor | CYP2D6 inhibitor | CYP3A4 inhibitor |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.12 | 453.54 | 7 | 1 | 162.07 | 2.48 | -5.74 | 0 | No | No | No | Yes | Yes | No | Yes |
2.12 | 467.57 | 7 | 1 | 162.07 | 2.74 | -6.05 | 0 | No | No | No | Yes | Yes | No | Yes |
1.14 | 361.45 | 6 | 1 | 152.84 | 1.36 | -3.85 | 0 | No | Yes | No | No | No | No | Yes |
2.14 | 452.56 | 6 | 2 | 178.86 | 2.24 | -5.73 | 0 | No | Yes | No | Yes | Yes | No | Yes |
1.15 | 441.51 | 7 | 1 | 152.84 | 2.73 | -5.68 | 0 | No | No | No | Yes | Yes | No | Yes |
2.15 | 455.53 | 7 | 1 | 152.84 | 3.05 | -5.99 | 0 | No | No | No | Yes | Yes | No | Yes |
1.16 | 441.51 | 7 | 1 | 152.84 | 2.73 | -5.68 | 0 | No | No | No | Yes | Yes | No | Yes |
2.16 | 455.53 | 7 | 1 | 152.84 | 3.13 | -5.99 | 0 | No | No | No | Yes | Yes | No | Yes |
2.17 | 437.54 | 6 | 1 | 152.84 | 2.85 | -5.88 | 0 | No | No | No | Yes | Yes | No | Yes |
1.18 | 363.42 | 7 | 2 | 173.07 | 0.81 | -4.12 | 0 | No | Yes | No | No | No | No | No |
2.18 | 377.44 | 7 | 2 | 173.07 | 1.19 | -4.43 | 0 | No | Yes | No | No | No | No | Yes |
2.2 | 376.46 | 6 | 2 | 178.86 | 0.69 | -3.88 | 0 | No | Yes | No | No | No | No | Yes |
1.23 | 390.49 | 6 | 1 | 156.08 | 1.08 | -3.69 | 0 | No | Yes | No | No | No | No | Yes |
1.25 | 432.52 | 7 | 1 | 165.31 | 0.92 | -3.5 | 0 | No | Yes | No | No | No | No | Yes |
2.25 | 446.55 | 7 | 1 | 165.31 | 1.16 | -3.81 | 0 | No | Yes | No | No | No | No | Yes |
1.26 | 444.58 | 6 | 1 | 156.08 | 1.97 | -5.02 | 0 | No | Yes | No | Yes | Yes | No | Yes |
2.26 | 458.6 | 6 | 1 | 156.08 | 2.24 | -5.33 | 0 | No | Yes | No | Yes | Yes | No | Yes |
3.11 | 345.44 | 4 | 0 | 110.55 | 3.22 | -5.49 | 0 | No | No | Yes | Yes | Yes | No | No |
3.12 | 355.5 | 2 | 0 | 112.49 | 4.62 | -6.9 | 0 | No | Yes | Yes | Yes | Yes | No | Yes |
3.14 | 409.5 | 4 | 0 | 101.32 | 4.71 | -6.95 | 0 | No | No | Yes | Yes | Yes | No | Yes |
4.14 | 333.4 | 4 | 1 | 112.18 | 3.44 | -5.51 | 0 | No | No | Yes | Yes | Yes | Yes | Yes |
3.16 | 421.54 | 4 | 0 | 110.55 | 4.44 | -7.01 | 0 | No | No | Yes | Yes | Yes | Yes | Yes |
3.19 | 544.74 | 4 | 0 | 168.5 | 6.07 | -9.65 | 2 | No | Yes | No | No | Yes | No | Yes |
The results of this study showed that almost all compounds obeyed the Lipinski’s rule. Only compound 3.19 exceeded the molecular weight of 500 g/mol and the value of consensus log P > 5. Therefore, the following compound (3.14) was chosen for further virtual screening and protein-ligand interaction analysis based on the value of the energy’s estimate.
The results of docking have shown that among the studied compounds, 6 molecules (2.14, 1.15, 2.15, 1.16, 3.16, 3.19) the binding affinity values (from -9.7 to -10.4 kcal/mol) due to NO- synthase (PDB: 6NGL) relative to the control ligand were exceeded. Compound 2.15 has formed a complex with oxidoreductase and a better docking score of -10.4 kcal/mol. The stability of the complex was characterized by the presence of hydrogen bonds between the ligand and SER413 (3.11 Å), ARG414 (2.92 Å), CYS415 (3.00 Å), TRP409 (3.02 Å). The interaction of hydrogen bonds plays a vital role in maintaining the stability of the attached Complex (
The docking’s result of the studied compounds with the NMDA-receptor GluN1has shown that the 1,2,4-triazole derivative 3.19 has the highest binding affinity energy of -10.3 kcal/mol, but the compound violates the Lipinski’s rule, so the next ligand 3.14 with an affinity of -10.1 kcal/mol was chosen. The binding mode is presented in (
The O1 atom of the carbonyl group has formed a weak hydrogen bond with the hydroxyl group of the THR126 residue (2.96 Å), the N1 atom of the 1,2,4-triazole ring is connected with the amino group of ASN128 (3.16 Å). Other hydrophobic, electrostatic, and unconventional hydrogen bonds were inherent in our complex: the electron cloud of the aromatic ring of the phenyl radical formed a π-alkyl contact with amino acid residues VAL181 (5.27 Å), LEU (4.92 Å). The presence of a fluorine atom causes a halogen bond with the carboxyl group of ASP224 (4.96 Å). Also, the π-anion bond is a stabilizing electrostatic interaction of the ASP224 carboxyl group (4.82 Å) with the polarizable Pi- electron cloud of the 3-fluorophenyl’s aromatic ring.
The molecular dynamics method was used to test the stability of Ligand-enzyme complexes. Thus, we could obtain important information about the dynamic behavior of the studied compounds considering the long trajectories, in the 100 ns time function and in the solvated medium. The physiological salt concentration was also maintained. After a cycle of 100 ns for each of the MD complexes, the simulation was analyzed for such parameters as: RMSD, RMSF, Rg, SASA, Hbonds, PCA. Molecular dynamics study was performed for complexes: proteins with the studied compounds that had the highest value of the docking index and exceeded the docking score of crystallographic comparison preparations (6NGJ_2.15; 4KFQ_3.14); proteins with crystallographic reference ligands, which were used to confirm the suitability of the molecular docking protocol, where for NO-synthase a complex of 6-(3-fluoro-5-(3-(methylamino)prop-1-in-1-yl)phenethyl)-4-methylpyridine-2-amine (6NGJ_STD), and for the NMDA GluN1 receptor, modeling was performed with 1-sulphanyl[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (4KFQ_STD). Also, for comparison, molecular modeling of proteins’ native forms (6NGJ_Apo; 4KFQ_Apo) was carried out.
All changes in the protein and protein-ligand complexes configuration were investigated by means of square deviation (RMSD) of the protein backbone skeleton’s coordinates during 100 ns of MD modeling. The RMSD graph shows that the calculated RMSD for the complex of NO-synthase and ligand 2.15 (Fig.
The RMSD analysis shows that the MD trajectories of the two studied complexes were generally stable throughout the simulation period.
The average position fluctuation is calculated from the standard deviation (RMSF) values of each residue to test the mobility or flexibility of protein residues during modeling. This allowed us to note that for NO-synthase and the corresponding complexes, the position of amino residues do not differ much. They showed a slight fluctuation difference between the native protein and the complexes, i.e. they maintained the same position of the main scaffold of the residues. The average RMSF value for the Apo form was 0.10 ± 0.07 nm, the RMSF of 6NGJ due to the compound 2.15 was 0.14 ± 0.08 nm, and for the reference ligand 0.15 ± 0.09 nm (Fig.
The rotation radius indicates the stability of biomolecules by measuring their structural compactness along the molecular dynamics trajectory. The Rg value is relatively constant and have a stable curve throughout the simulation for the two 6NGJ_Apo complexes, 6NGJ_2.15 and 6NGJ_STD, and they are in average 2.29 ± 0.013 nm, 2.33 ± 0.017 nm, and 2.31 ± 0.019 nm, respectively (Fig.
Calculating the surface accessible solvent area (SASA) helps you to calculate the surface area of the protein and complex that is available for the solvent. The average SASA value is calculated for the native protein is 225.66 nm ± 1.50 nm, while the protein complexes with the studied compound 2.15 and the reference ligand had values of 235.87 nm ± 1.67 nm and 237.24 ± 1.52 nm, which indicates a slight difference between the studied systems (Fig.
Hydrogen bonds are a key indicator of binding specificity between a receptor and a ligand. The average values of H-bonds after the simulation period of 100 ns formed between NO-synthase and molecule 2.15 were 2.40 ± 1.63 (Fig.
Principal Component Analysis (PCA) is a statistical calculation for reducing the amount of data, which in our case was based on extracting significant movements of backbone Cα atoms due to the ligand. The first 40 eigenvectors and eigenvalues of the two studied enzymes with and without ligands were selected for this study. The first 40 eigenvectors were 99.89% for 6NGJ_2.15, 99.42% for 6NGJ_STD, 99.17% for 4KFQ_3.14, and 99.99% for 4KFQ_STD. The flexibility of all systems was analyzed by calculating the trace value of the diagonalized covariance matrix, which is the sum of the Eigen values. For the 6NGJ_2.15 complex, this value is 4.08 nm2, while 6NGJ_STD is 1.08 nm2 (Fig.
Summarizing all the above mentioned, we can conclude that 2.15 and 3.14 compounds for which molecular dynamic characteristics were studied confirmed the docking study, since these tested molecules tended to remain bound to the selected enzymes and did not fall out of the active site throughout the simulation. It should be noted that the synthase complex with ligand 2.15, was although quite stable, but was unfortunately inferior in stability to the reference complex. The 6NGJ_STD complex occupied a smaller confirmation space, had fewer residual fluctuations, and even showed less flexibility of the protein skeleton compared to Apo synthase. In contrast, the NMDA receptor complex with 3.14 has showed a fairly significant difference from the reference complex and Apo protein. The studied ligand caused a greater compactness of the enzyme structure, the complex itself had fewer residual fluctuations, therefore it was more stable than the reference 4KFQ_STD complex.
The free binding energy of the simulated complexes was estimated by the MM-PBSA method for the last 20 ns trajectories (Table
Complexes | Complexes binding energy (kcal/mol) | Van der Waal energy (EvdW) (kcal/mol) | Electrostattic energy (Eelec) (kcal/mol) | Polar solvation energy (DG polar) (kcal/mol) | SASA energy (kcal/mol) |
---|---|---|---|---|---|
6NGJ_2.15 | 5.33 ± 2.79 | -52.54 ± 3.72 | -27.46 ± 1.30 | 55.84 ± 2.40 | 29.50 ± 1.37 |
6NGJ_STD | 4.86 ± 2.05 | -35.77 ± 2.74 | -7.44 ± 4.34 | 26.12 ± 5.03 | 21.94 ± 2.08 |
4KFQ_3.14 | -24.14 ± 0.32 | -34.99 ± 2.88 | -189.05 ± 3.35 | 177.61± 1.69 | 22.28 ± 0.56 |
4KFQ_STD | 1.24 ± 2.77 | -19.13 ± 1.25 | -165.11 ± 9.28 | 169.22 ± 7.61 | 16.26 ± 0.72 |
The binding energy of the complex showed a small difference between the studied ligand 2.15 and the reference ligand. Although the free binding energy was higher in the studied complex, similar stability of the systems was still present. Instead of, the 4KFQ complex shows better binding affinity to compound 3.14 (-24.14 ± 0.32 kcal/mol) than to the reference ligand 1.24 ± 2.77 kcal/mol. The electrostatic energy shows significant moderate values in the case of the 4KFQ_3.14 complex. The binding energy showed the stability of the complex, and we can assume that ligand 3.14 can be used as a potential inhibitor/antagonist for the selected enzyme.
In this study, we’ve used the in silico approach to identify bioactive compounds that can inhibit six proteins responsible for antioxidant regulation. The number of selected 1,2,4-trazole derivatives in 112 molecules was sufficient to obtain promising results in terms of the potential to exhibit inhibitory activity. Six molecules have shown the best Affinity value against NO-synthase (from -9.7 to -10.4 kcal/mol), exceeding the ligand reference values. And twenty-three hits had a higher docking score (from -8.4 to -10.3 kcal/mol) to the N-methyl-d-aspartate (NMDA) GluN1 receptor than the reference ligand. The ADME prediction of priority ligands has revealed high bioavailability for the analyzed molecules and only one compound 3.19, which had a violation of the Lipinski’s rule, so the next compound 3.14 was investigated instead. Molecular modeling study of the two systems with the best affinity indicators has revealed the stable complexes formation throughout the simulation. In particular, analysis based on molecular dynamic characteristics (RMSD, RMSF, Rg, SASA and PCA) has shown that the interaction of the ligand 3.14 with 4KFQ was much more stabilizing and conformationaly favorable compared to the reference. Calculations of the binding free energy of the complex have shown similar values of the studied ligand with oxidoreductase, but exceeded them compared to the reference ligand. In contrast, ligand 3.14 had better results in terms of MM-PBSA binding energy, suggesting that this molecule is likely to be a good hit in the discovery of competitive inhibitors of the NMDA receptor GluN1. Thus, our theoretical results indicate that the studied molecules can be used as potential candidates for further in vitro and in vivo studies on antioxidant activity.
The authors have no support to report.